Cardiolyse provides a chronic and post-discharge cardiovascular disease patient monitoring platform with medical-grade AI heart health analytics (CE class 2a, 19 arrhythmias) that enables remote vital sign monitoring and personalized patient reports for early diagnostics and better care.

 

    • Founding year:
2016

    • Development phase:
Market-ready

    • Funding stage:
Late-seed

    • Website:

    • Contact person info:
anna.starynska(at)cardiolyse.com

    • Team members:
11